Drug Information

Drug General Information
Drug ID
D0E9TP
Former ID
DAP000866
Drug Name
Sulodexide
Indication Central or sensorineural tinnitus [ICD9: 388.3; ICD10:H93.1] Approved [536297]
Therapeutic Class
Antithrombotic Agents
CAS Number
CAS 57821-29-1
SuperDrug ATC ID
B01AB11
Target and Pathway
Target(s) Antithrombin-III Target Info Activator [537594], [538076]
KEGG Pathway Complement and coagulation cascades
PANTHER Pathway Blood coagulation
Pathway Interaction Database Glypican 1 network
Reactome Intrinsic Pathway of Fibrin Clot Formation
Common Pathway of Fibrin Clot Formation
WikiPathways Complement and Coagulation Cascades
Formation of Fibrin Clot (Clotting Cascade)
References
Ref 536297Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006 Nov;11(4):709-24.
Ref 537594Management of tinnitus: oral treatment with melatonin and sulodexide. J Biol Regul Homeost Agents. 2009 Apr-Jun;23(2):103-10.
Ref 538076Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide. Med Res Rev. 1998 Jan;18(1):1-20.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.